http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02070537-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9bf8ddd7435c69cd1b353b1292981d68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ace8503c24fcc865c72d6f07dd01e53d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3196fc7680efbf92d6404f3ae5b0425
publicationDate 2002-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02070537-A3
titleOfInvention Fusidic acid derivatives
abstract Novel 17,20-methanofusidic acid derivatives are used in pharmaceutical compositions for the treatment of infections, in particular in topical compositions for the treatment of skin or eye infections.
priorityDate 2001-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4162259-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3000226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53911549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413684

Total number of triples: 24.